Category: Liver Science

All Podcast Categories
S4-40 - Review of Paris NASH 2023

S4-40 – Review of Paris NASH 2023

Surfing NASH returns to its regular podcast schedule with a review of the recently concluded Paris NASH meeting. Presenters and KOLs Scott Friedman and Laurent Castera join Jörn Schattenberg, Louise Campbell and Roger Green for an exciting episode that focuses largely on important and emerging questions surrounding the use of NITs in a landscape which features drug approval. Surf on to learn much more from what always pans out to be an incredibly in-depth and insightful event.

S4-39.4 - MASEF: Where will we be in 2 years?

S4-39.4 – MASEF: Where will we be in 2 years?

Mazen Noureddin discusses his work on a Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF) with Jörn Schattenberg, Louise Campbell and Roger Green. This final session considers a few more populations who might benefit from such a test before the panelists field a final question that speculates what MASEF will look like 2 years from today.

S4-39.2 - MASEF: Cost Effectiveness and Application Settings

S4-39.2 – MASEF: Cost Effectiveness and Application Settings

In this conversation, Mazen Noureddin fields questions from Jörn Schattenberg, Louise Campbell and Roger Green around different application settings for the Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF). The group discusses pros and cons of different approaches and speculate on challenges such as cost effectiveness and ease of use.

S4-39 - The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

S4-39 – The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)

Surfing NASH returns to its regular program with a fresh episode and some fascinating and progressive ideas on non-invasive testing with Mazen Noureddin. For this feature, Mazen talks about his recent work in serum identification of at-risk MASH and the Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF). The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) respond with their thoughts and varying perspectives.

S4-35.4 - Looking Forward at the SurfingNASH Program

S4-35.4 – Looking Forward at the SurfingNASH Program

The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) discuss the big stories thus far for 2023 and share previews of what to expect from the SurfingNASH program in the coming months. This conversation hones in on what the audience can expect and look forward to learn more about in the coming months.

S4-35.3 - Strengthening Patient Involvement, NIT Development and Lessons from AI

S4-35.3 – Strengthening Patient Involvement, NIT Development and Lessons from AI

The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) discuss the big stories thus far for 2023 and share previews of what to expect from the SurfingNASH program in the coming months. This conversation discusses the growing trend of patient involvement, the factors for and benefits of NIT development, lessons from artificial intelligence and more.

S4-35.2 - Challenges Associated with Communicating New Nomenclature

S4-35.2 – Challenges Associated with Communicating New Nomenclature

The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) discuss the big stories thus far for 2023 and share previews of what to expect from the SurfingNASH program in the coming months. This conversation focuses largely on the various challenges associate with adopting and communicating new nomenclature for liver disease.

S4-35.1 - High-Level Recap of Two Key Events for 2023 Thus Far

S4-35.1 – High-Level Recap of Two Key Events for 2023 Thus Far

The Surfers (Jörn Schattenberg, Louise Campbell and Roger Green) discuss the big stories thus far for 2023 and share previews of what to expect from the SurfingNASH program in the coming months. This conversation introduces two topics to expound on which standout amid a year that proves to be rife with rich, new information.

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.